Literature DB >> 23157328

Targeted deletion of the antisilencer/enhancer (ASE) element from intron 1 of the myelin proteolipid protein gene (Plp1) in mouse reveals that the element is dispensable for Plp1 expression in brain during development and remyelination.

Glauber B Pereira1, Fanxue Meng, Neriman T Kockara, Baoli Yang, Patricia A Wight.   

Abstract

Myelin proteolipid protein gene (Plp1) expression is temporally regulated in brain, which peaks during the active myelination period of CNS development. Previous studies with Plp1-lacZ transgenic mice demonstrated that (mouse) Plp1 intron 1 DNA is required for high levels of expression in oligodendrocytes. Deletion-transfection analysis revealed the intron contains a single positive regulatory element operative in the N20.1 oligodendroglial cell line, which was named ASE (antisilencer/enhancer) based on its functional properties in these cells. To investigate the role of the ASE in vivo, the element was deleted from the native gene in mouse using a Cre/lox strategy. Although removal of the ASE from Plp1-lacZ constructs profoundly decreased expression in transfected oligodendroglial cell lines (N20.1 and Oli-neu), the element was dispensable to achieve normal levels of Plp1 gene expression in mouse during development (except perhaps at postnatal day 15) and throughout the remyelination period following cuprizone-induced (acute) demyelination. Thus, it is possible that the ASE is non-functional in vivo, or that loss of the ASE from the native gene in mouse can be compensated for by the presence of other regulatory elements within the Plp1 gene.
© 2012 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23157328      PMCID: PMC3557533          DOI: 10.1111/jnc.12092

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  46 in total

1.  Structure and expression of the mouse myelin proteolipid protein gene.

Authors:  W B Macklin; C W Campagnoni; P L Deininger; M V Gardinier
Journal:  J Neurosci Res       Date:  1987       Impact factor: 4.164

2.  Myelination in rat brain: changes in myelin composition during brain maturation.

Authors:  W T Norton; S E Poduslo
Journal:  J Neurochem       Date:  1973-10       Impact factor: 5.372

3.  Analyses of proteolipid protein mutants show levels of proteolipid protein regulate oligodendrocyte number and cell death in vitro and in vivo.

Authors:  R P Skoff; I Saluja; D Bessert; X Yang
Journal:  Neurochem Res       Date:  2004-11       Impact factor: 3.996

4.  Essential and redundant functions of the MyoD distal regulatory region revealed by targeted mutagenesis.

Authors:  Jennifer C J Chen; Rageshree Ramachandran; David J Goldhamer
Journal:  Dev Biol       Date:  2002-05-01       Impact factor: 3.582

5.  Expression of myelin genes: comparative analysis of Oli-neu and N20.1 oligodendroglial cell lines.

Authors:  Glauber B Pereira; Anna Dobretsova; Hamdan Hamdan; Patricia A Wight
Journal:  J Neurosci Res       Date:  2011-04-06       Impact factor: 4.164

Review 6.  Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research.

Authors:  Carol Kilkenny; William J Browne; Innes C Cuthill; Michael Emerson; Douglas G Altman
Journal:  PLoS Biol       Date:  2010-06-29       Impact factor: 8.029

7.  Myelin proteolipid proteins promote the interaction of oligodendrocytes and axons.

Authors:  D A Yool; M Klugmann; M McLaughlin; D A Vouyiouklis; L Dimou; J A Barrie; M C McCulloch; K A Nave; I R Griffiths
Journal:  J Neurosci Res       Date:  2001-01-15       Impact factor: 4.164

8.  Repression of myelin proteolipid protein gene expression is mediated through both general and cell type-specific negative regulatory elements in nonexpressing cells.

Authors:  Shenyang Li; Anna Dobretsova; Natalia A Kokorina; Patricia A Wight
Journal:  J Neurochem       Date:  2002-07       Impact factor: 5.372

9.  Firefly luciferase gene: structure and expression in mammalian cells.

Authors:  J R de Wet; K V Wood; M DeLuca; D R Helinski; S Subramani
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

10.  A myelin proteolipid protein-LacZ fusion protein is developmentally regulated and targeted to the myelin membrane in transgenic mice.

Authors:  P A Wight; C S Duchala; C Readhead; W B Macklin
Journal:  J Cell Biol       Date:  1993-10       Impact factor: 10.539

View more
  4 in total

1.  The wmN1 enhancer region in intron 1 is required for expression of human PLP1.

Authors:  Hamdan Hamdan; Pankaj Patyal; Neriman T Kockara; Patricia A Wight
Journal:  Glia       Date:  2018-04-23       Impact factor: 7.452

2.  The wmN1 Enhancer Region of the Mouse Myelin Proteolipid Protein Gene (mPlp1) is Indispensable for Expression of an mPlp1-lacZ Transgene in Both the CNS and PNS.

Authors:  Pankaj Patyal; Neriman T Kockara; Patricia A Wight
Journal:  Neurochem Res       Date:  2019-11-28       Impact factor: 3.996

3.  In Silico Perspectives on the Prediction of the PLP's Epitopes involved in Multiple Sclerosis.

Authors:  Zahra Zamanzadeh; Mitra Ataei; Seyed Massood Nabavi; Ghasem Ahangari; Mehdi Sadeghi; Mohammad Hosein Sanati
Journal:  Iran J Biotechnol       Date:  2017-03       Impact factor: 1.671

4.  Identifying oligodendrocyte enhancers governing Plp1 expression.

Authors:  Dongkyeong Kim; Hongjoo An; Chuandong Fan; Yungki Park
Journal:  Hum Mol Genet       Date:  2021-11-16       Impact factor: 5.121

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.